(2) credits on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml

(2) hours on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml

(2) credits on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml